304
Views
4
CrossRef citations to date
0
Altmetric
Research Article

N–Acyl–3,5–bis(arylidene)-4-piperidones and related compounds which stimulate fyn kinase

, , , &
Pages 451-455 | Received 12 Oct 2006, Accepted 05 Dec 2006, Published online: 04 Oct 2008
 

Abstract

This study is part of a long term project designed to explore the hypothesis that stimulation of cancer cells followed by treatment with one or more cytotoxic agents may create greater damage to tumours than to the corresponding normal tissues. The aim of the present investigation was to discover various compounds which stimulate a protein tyrosine kinase, namely fyn kinase. The N-acyl-3,5-bis(arylidene)-4-piperidones and related analogues activated this enzyme using concentrations of 25 μM while representative molecules achieved this result at 0.1 μM. Molecular modelling suggested that the compounds interact transiently with the ATP binding site of fyn kinase thereby enhancing the catalytic phosphorylation of proteins. In the future, candidate antineoplastic agents will be designed which incorporate the structural features of these enzyme stimulators with the goal of their being formed in vitro and in vivo prior to the release of cytotoxins.

Acknowledgements

The authors thank the Canadian Institutes of Health Research for operating grants to R. K. Sharma and J. R. Dimmock while appreciation is extended to the Canadian Foundation for Innovation who awarded a grant to T. A. Haas. Ms B. McCullough is thanked for typing various drafts of this paper.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.